{{Drugbox
| Watchedfields = changed
| verifiedrevid = 444188860
| IUPAC_name = 4-(3-methylbut-2-enyl)-1,2-di(phenyl)pyrazolidine-3,5-dione
| image = feprazone.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|feprazone}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number =  
| ATC_prefix = M02
| ATC_suffix = AA16
| PubChem = 35455
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 32612
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 7BVX6J0CGR
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01305

<!--Chemical data-->
| C=20 | H=20 | N=2 | O=2 
| molecular_weight = 320.385 g/mol
| smiles = O=C2N(c1ccccc1)N(C(=O)C2C\C=C(/C)C)c3ccccc3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H20N2O2/c1-15(2)13-14-18-19(23)21(16-9-5-3-6-10-16)22(20(18)24)17-11-7-4-8-12-17/h3-13,18H,14H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RBBWCVQDXDFISW-UHFFFAOYSA-N
}}

'''Feprazone''' (or '''prenazone''')  is a drug used for joint and muscular [[pain]].<ref>{{Cite journal 
| doi = 10.1016/0041-008X(82)90222-8 
| last1 = Koyama | first1 = T. 
| last2 = Izawa | first2 = Y. 
| last3 = Wada | first3 = H. 
| last4 = Makita | first4 = T. 
| last5 = Hashimoto | first5 = Y. 
| last6 = Enomoto | first6 = M. 
| title = Toxicological aspects of feprazone, a new nonsteroidal anti-inflammatory drug 
| journal = Toxicology and applied pharmacology 
| volume = 64 
| issue = 2 
| pages = 255â€“270 
| year = 1982 
| pmid = 7123554
}}</ref>

It is an analog of [[butazone]] but instead of a ''n''-butyl group it is [[prenylated]].
==References==
{{reflist}}

{{Anti-inflammatory and antirheumatic products}}
{{Topical products for joint and muscular pain}}

[[Category:Nonsteroidal anti-inflammatory drugs]]
[[Category:Pyrazolidindiones]]


{{musculoskeletal-drug-stub}}